UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028240
Receipt number R000032133
Scientific Title Phase II clinical trial of multimodal analgesia for postoperative pain management in patients undergoing laparoscopic colorectal resection for cancer
Date of disclosure of the study information 2017/07/14
Last modified on 2020/01/15 17:18:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II clinical trial of multimodal analgesia for postoperative pain management in patients undergoing laparoscopic colorectal resection for cancer

Acronym

Phase II clinical trial of multimodal analgesia in patients undergoing laparoscopic colorectal resection

Scientific Title

Phase II clinical trial of multimodal analgesia for postoperative pain management in patients undergoing laparoscopic colorectal resection for cancer

Scientific Title:Acronym

Phase II clinical trial of multimodal analgesia in patients undergoing laparoscopic colorectal resection

Region

Japan


Condition

Condition

Colorectal cancer

Classification by specialty

Surgery in general Gastrointestinal surgery Anesthesiology
Operative medicine Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the use of a multimodal analgesia in patients undergoing laparoscopic colorectal resection for cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative stay

Key secondary outcomes

Pain score (NRS,PRS), postoperative complications, frequency of PCA, time to walk, time to food intake


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Multimodal analgesia

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

# Pathologically proven carcinoma.
# Primary tumor located at colon or upper rectum
# Rectal cancers of which the lower border is located below the peritoneal reflection are excluded.
# Aged 20 to 85 years old
# Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
# Written informed consent

Key exclusion criteria

# Allergy to any drugs used in this trial
Distant metastases
# Interstitial pneumonia or fibroid lung.
# Uncontrolled diabetes mellitus.
# Uncontrolled hypertension
# Uncontrolled urinary disorder
# Unable to provide informed consent
# Those considered inappropriate for participation in this trial.

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Junichiro
Middle name
Last name Kawamura

Organization

Kindai University

Division name

Surgery

Zip code

589-8511

Address

377-2 Ohno higashi, Osaka sayama Osaka, 589-8511, Japan

TEL

072-366-0221

Email

kawamuraj@med.kindai.ac.jp


Public contact

Name of contact person

1st name Shohko
Middle name
Last name Matsukawa

Organization

Kindai University

Division name

Surgery

Zip code

589-8511

Address

377-2 Ohno higashi, Osaka sayama Osaka, 589-8511, Japan

TEL

072-366-0221

Homepage URL


Email

profsec-matsukawa@surg.med.kindai.ac.jp


Sponsor or person

Institute

Kindai University Faculty of Medicine
Department of Surgery

Institute

Department

Personal name



Funding Source

Organization

Kindai University Faculty of Medicine
Department of Surgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kindai University Hospital IRB

Address

377-2 Ohno higashi, Osaka sayama Osaka, 589-8511, Japan

Tel

072-366-0221

Email

zizen@med.kindai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 07 Month 10 Day

Date of IRB

2017 Year 07 Month 10 Day

Anticipated trial start date

2017 Year 07 Month 14 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 07 Month 14 Day

Last modified on

2020 Year 01 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032133


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name